Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy

CITEDBY Reports

  1. Farid Kheloufi, Eric Bellissant, Laurent Cotte, Isabelle Poizot-Martin, Sylvie Quaranta, Rodolphe Garraffo, Aurélie Barrail-Tran, Alain Renault, Isabelle Fournier, Bruno Lacarelle, Marc Bourlière, Jean-Michel Molina, Caroline Solas, . Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS, 2016; 30(13): 2085.
    Crossref